BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 4974308)

  • 1. Congenital dysfibrinogenemia: fibrinogen Detroit.
    Mammen EF; Prasad AS; Barnhart MI; Au CC
    J Clin Invest; 1969 Feb; 48(2):235-49. PubMed ID: 4974308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.
    Gralnick HR; Givelber HM; Shainoff JR; Finlayson JS
    J Clin Invest; 1971 Sep; 50(9):1819-30. PubMed ID: 5564389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen St. Louis: a new inherited fibrinogen variant, coincidentally associated with hemophilia A.
    Sherman LA; Gaston LW; Kaplan ME; Spivack AR
    J Clin Invest; 1972 Mar; 51(3):590-7. PubMed ID: 4622105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen New Orleans: hereditary dysfibrinogenemia with an A alpha chain abnormality.
    Andes WA; Chavin SI; Beltran G; Stuckey WJ
    Thromb Res; 1982 Jan 1-15; 25(1-2):41-50. PubMed ID: 6801812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysfibrinogenemia associated with liver disease.
    Palascak JE; Martinez J
    J Clin Invest; 1977 Jul; 60(1):89-95. PubMed ID: 874092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release.
    Lane DA; Cuddigan B; VanRoss M; Kakkar VV
    Br J Haematol; 1980 Mar; 44(3):483-94. PubMed ID: 6769460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen Cleveland II. An abnormal fibrinogen with defective release of fibrinopeptide A.
    Crum ED; Shainoff JR; Graham RC; Ratnoff OD
    J Clin Invest; 1974 May; 53(5):1308-19. PubMed ID: 4856883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatographic, ultracentrifugal, and related studies of fibrinogen "Baltimore".
    Mosesson MW; Beck EA
    J Clin Invest; 1969 Sep; 48(9):1656-62. PubMed ID: 5822576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Congenital dysfibrinogenemia. Report on a new family (fibrinogen "Wiesbaden")].
    Winckelmann G
    Thromb Diath Haemorrh Suppl; 1973; 55():345-56. PubMed ID: 4216115
    [No Abstract]   [Full Text] [Related]  

  • 10. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
    Al-Mondhiry H; Galanakis D
    J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule.
    Gralnick HR; Givelber H; Abrams E
    N Engl J Med; 1978 Aug; 299(5):221-6. PubMed ID: 207986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen ""New York"--an abnormal fibrinogen associated with thromboembolism: functional evaluation.
    Al-Mondhiry H; Bilezikian SB; Nossel HL
    Blood; 1975 May; 45(5):607-19. PubMed ID: 235338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An abnormal inherited fibrinogen (fibrinogen Genova) with delayed fibrin aggregation.
    Hassan HJ; Orlando M; Tonini GP; Casalbore P; Sarti A; Boeri E; Giacchino R; Tentori L; Mori PG
    Scand J Haematol; 1982 Oct; 29(4):287-94. PubMed ID: 7178834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen Logroño. A new case of congenital dysfibrinogenemia.
    Rocha E; Lasierra J; Narvaiza MJ; Vilades E; Palacios E; Fernandez J
    Ric Clin Lab; 1984; 14(4):663-72. PubMed ID: 6522973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH; Crowe MF
    J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitution.
    Borrell M; Vila L; Solá J; Coll I; Fontcuberta J
    Haemostasis; 1990; 20(1):1-7. PubMed ID: 2323678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen kaiserslautern III: a new case of congenital dysfibrinogenemia with aalpha 16 arg-->cys substitution.
    Loreth RM; Meyer M; Albert FW
    Haemostasis; 2001; 31(1):12-7. PubMed ID: 11408744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen Valencia. A new case of congenital dysfibrinogenemia.
    Aznar J; Fernandez-Pavón A; Regañón E; Vila V; Orellana F
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):564-77. PubMed ID: 4217955
    [No Abstract]   [Full Text] [Related]  

  • 19. An inherited qualitative abnormality in plasma fibrinogen: fibrinogen Cleveland.
    Forman WB; Ratnoff OD; Boyer MH
    J Lab Clin Med; 1968 Sep; 72(3):455-72. PubMed ID: 5674077
    [No Abstract]   [Full Text] [Related]  

  • 20. A kinetic method for characterization of heterogenous fibrinogen and its application to fibrinogen Grand Rapids, a congenital dysfibrinogenemia.
    Higgins DL; Lewis SD; Penner JA; Shafer JA
    Thromb Haemost; 1982 Oct; 48(2):182-6. PubMed ID: 6217579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.